## Abstract The preparation of SQ‐14225‐^14^C, anti‐hypertensive drug, is described. The starting material, methacrylic acid‐1‐^14^C, was prepared in a high yield by carbonation of the corresponding Grignard reagent with ^14^CO~2~. The final product was obtained from the acid through a four step sy
Synthesis of N-[N-[(S)-1-ethoxy[14C]carbonyl-3-phenyl[1-14C]propyl]-L-alanyl]-N-(indan-2-YL)glycine hydrochloride ([14C]CV-3317)
✍ Scribed by Masazumi Watanabe; Norio Tada; Katsumi Itoh; Nobuyoshi Hayashi
- Publisher
- John Wiley and Sons
- Year
- 1987
- Tongue
- French
- Weight
- 176 KB
- Volume
- 24
- Category
- Article
- ISSN
- 0022-2135
No coin nor oath required. For personal study only.
✦ Synopsis
N-[N-[(S)-1-Ethoxycarbonyl
-3-phenylpropyll-La l a ~y l ~-E -T i n d a n -2 -y 1 ) glycine hydrochloride (CV-3317) , a new potent angiotensin converting enz e inhibitor, was labeled with carbon-14. Diethyl [U-'C]oxalate was condensed with ethyl 3-phenylpropionate, subsequently decarboxylated to yield ethyl [1,2-14C]-2-oxo-4-phenylbutyrate. The reductive condensation of the latter with tert-butyl E-L-alanyl-N-('ndan-2-yl)glycinate followed b y y d r o l y s i s afforded [15 CICV-3317 in an overall radiochemical yield of 17.4 %.
📜 SIMILAR VOLUMES
## Abstract Two benzodiazepine CCK antagonists __N__‐(2,3‐dihydro‐1‐[^14^C]methyl‐2‐oxo‐5‐phenyl‐1H 1,4‐benzodiazepin‐3‐yl)‐benzamide **2** and __N__‐(2,3‐dihydro‐1‐[^14^C]methyl‐2‐oxo‐5‐phenyl‐1H‐1,4‐benzodiazepin‐3‐yl)‐[^14^C]methyl‐benzamide **3** were synthesized in high yields through the reac
## Abstract The title compound (1) was synthesized by a 7‐step sequence. 4‐Amino‐2‐hydroxy‐[carbonyl‐^14^C]benzoic acid (1) was selectively methylated to provide the ether ester 2, which was smoothly chlorinated in acetic acid to give 3. The ester was hydrolyzed with aqueous potassium hydroxide to
The partial ergoline LY228729 (1) which was a potent 5HT 1A agonist has been studied clinically. Somewhat later, a related analog, (S)-di-n-propyl-(8-isoxazol-5-yl-1,2,3,4-tetrahydronaphthalen-2-yl)amine (2a) which in addition to potent 5HT 1A agonist activity was a muscarinic antagonist, was chosen
The title compound, CGS 148248, was synthesized with a '%-label in the azepine ring in 14 steps starting with l-bromo-3-phenylpropane (1> and K1%N in an overall yield of 1.31%. The reaction of I with K 1 k N yielded the nitrile 2 which upon hydrolysis followed by ring closure gave a-tetral~ne-l-~~c